ArticleYonsei medical journal2016

Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.

Sujuan Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.